There is no question that the past 5 decades have been transformative for ophthalmologists and their patients. As part of ...
Opus Genetics has completed a Type B Regenerative Medicine Advanced Therapy (RMAT) meeting with the US Food and Drug ...
The company describes KSI-101 as a “novel, potent, and high-strength (100 mg/mL) antibody-based investigational therapy with ...
An expert demonstrates how to safely co-manage AMD and GA using staggered dual-pathway treatment to maintain stability and ...
After announcing earlier this week the appointment of Andreas Wallnöfer, PhD, MBA, to its Board of Directors, Optigo ...
An expert summarizes real-world GA management lessons, highlighting personalized imaging-guided care and patient-centered ...
PolyActiva and RareSight collaborate to create innovative therapies for rare pediatric retinal diseases, aiming to transform ...
An expert outlines vision-preserving strategies for monocular high-risk GA, emphasizing early intervention and tailored ...
My Eyes is available on Amazon Prime Video and aims to broaden public recognition of genetic eye disease while celebrating ...
I eventually was diagnosed with TED by a TED Specialist, but it took years, repeated visits, and a lot of “I'm fine” to get there. It took nine months, five doctors with multiple specialties, along ...
In this inaugural episode of the Ophthalmology Times ® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, of Vance ...
4D Molecular Therapeutics (4DMT) released positive interim 1.5- to 3.5-year data from the phase 1/2 PRISM clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback